AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Oct. 30, 2026

CDC Report Reveals Shortfall in Omega-3s Essential to Heart and Brain Health, Underscoring Value of Test-Based Nutrition

EIN Presswire

fallback image
Oct. 23, 2026

SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026

GlobeNewswire, Inc.

fallback image
Oct. 19, 2026

Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease

GlobeNewswire, Inc.

fallback image
Oct. 15, 2026

Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Oct. 14, 2026

Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

GlobeNewswire, Inc.

fallback image
Oct. 15, 2026

QUOIA Launches with All-Star Musical Collaboration Inspired by Iceland’s Wild Landscapes

EIN Presswire

fallback image
Oct. 29, 2026

Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

GlobeNewswire, Inc.

fallback image
Oct. 28, 2026

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

GlobeNewswire, Inc.

fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

fallback image
Sep. 23, 2026

NV26 Readiness: 352d SOW Integrates with NATO Allies in Iceland

DVIDS - Georgia

fallback image
Sep. 18, 2026

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Sep. 2, 2026

Seabees Modernize Airfield Repair on Historical Iceland Footprint

DVIDS - Georgia

fallback image
Aug. 28, 2026

Defending the “High North”, Exercise Northern Viking 2026 kicks off in Iceland

DVIDS - Georgia

fallback image
Aug. 21, 2026

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

GlobeNewswire, Inc.

fallback image
Aug. 19, 2026

North America’s Authentic Icelandic Skyr Celebrates Autumn: Icelandic Provisions Launches Pumpkin Spice

EIN Presswire

fallback image
Aug. 18, 2026

Exercise Northern Viking 2026 Marks 75 Years Of U.S.-Iceland Defense Cooperation

DVIDS - Georgia

fallback image
Jul. 9, 2026

Icelandirect Earns SSCI Certification, Strengthening Its Ability to Serve Brands Selling Across Major Retail Channels

GlobeNewswire, Inc.

fallback image
Oct. 20, 2026

Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
May 27, 2026

Icelandirect Achieves FSSC 22000 Certification, Reinforcing Its Commitment to the Highest Standards in Supplement Manufacturing

GlobeNewswire, Inc.

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: